- Home
- TVRD vs PKE Comparison
TVRD vs PKE Comparison
Compare TVRD & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- PKE
- Stock Information
- Founded
- TVRD 2017
- PKE 1954
- Country
- TVRD United States
- PKE United States
- Employees
- TVRD N/A
- PKE N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- PKE Military/Government/Technical
- Sector
- TVRD Health Care
- PKE Industrials
- Exchange
- TVRD Nasdaq
- PKE Nasdaq
- Market Cap
- TVRD 246.5M
- PKE 260.2M
- IPO Year
- TVRD N/A
- PKE N/A
- Fundamental
- Price
- TVRD $25.77
- PKE $13.61
- Analyst Decision
- TVRD Strong Buy
- PKE
- Analyst Count
- TVRD 3
- PKE 0
- Target Price
- TVRD $60.67
- PKE N/A
- AVG Volume (30 Days)
- TVRD 56.7K
- PKE 44.7K
- Earning Date
- TVRD 05-13-2025
- PKE 07-15-2025
- Dividend Yield
- TVRD N/A
- PKE 3.67%
- EPS Growth
- TVRD N/A
- PKE N/A
- EPS
- TVRD N/A
- PKE 0.29
- Revenue
- TVRD N/A
- PKE $62,026,000.00
- Revenue This Year
- TVRD N/A
- PKE N/A
- Revenue Next Year
- TVRD N/A
- PKE N/A
- P/E Ratio
- TVRD N/A
- PKE $47.03
- Revenue Growth
- TVRD N/A
- PKE 10.75
- 52 Week Low
- TVRD $8.13
- PKE $11.96
- 52 Week High
- TVRD $34.31
- PKE $15.57
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- PKE 46.01
- Support Level
- TVRD N/A
- PKE $13.48
- Resistance Level
- TVRD N/A
- PKE $14.17
- Average True Range (ATR)
- TVRD 0.00
- PKE 0.30
- MACD
- TVRD 0.00
- PKE -0.06
- Stochastic Oscillator
- TVRD 0.00
- PKE 15.24
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.